Jump to main content
Jump to site search

Issue 21, 2017
Previous Article Next Article

Novel solid forms of lonidamine: crystal structures and physicochemical properties

Author affiliations

Abstract

Lonidamine finds potential applications in cancer treatments, and its current marketed solid form, the sodium salt, displays poor solubility. The presence of a single carboxylic acid group makes it an ideal target for co-crystal design as design strategies involving carboxylic acid groups are well-established. CSD statistics combined with known hydrogen bonding preferences allowed suitable co-former selection which resulted in nine new multicomponent crystals with pharmaceutically acceptable co-formers. These included co-crystals, salts and some hybrid (co-crystal salt) structures. All the solid forms were characterized by X-ray diffraction techniques with subsequent measurement of physicochemical properties, such as stability, solubility, and dissolution rate. It was found that the co-formers were able to modulate the properties of lonidamine.

Graphical abstract: Novel solid forms of lonidamine: crystal structures and physicochemical properties

Back to tab navigation

Supplementary files

Article information


Submitted
05 apr. 2017
Accepted
27 apr. 2017
First published
27 apr. 2017

CrystEngComm, 2017,19, 2925-2935
Article type
Paper

Novel solid forms of lonidamine: crystal structures and physicochemical properties

L. K. Mapp, S. J. Coles and S. Aitipamula, CrystEngComm, 2017, 19, 2925
DOI: 10.1039/C7CE00651A

Social activity

Search articles by author

Spotlight

Advertisements